Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Haley, Connie A. ; Macias, Patricia ; Jasuja, Supriya ; Jones, Betsy A. ; Rowlinson, Marie-Claire ; ... More +
Haley, Connie A. ; Macias, Patricia ; Jasuja, Supriya ; Jones, Betsy A. ; Rowlinson, Marie-Claire ; Jaimon, Roshni ; Onderko, Pennelyn ; Darnall, Elaine ; Gomez, Maria E. ; Peloquin, Charles ; Ashkin, David ; Goswami, Neela D. Less -
Description:
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months posttreatment. We report on a patient who completed the regimen using a lower linezolid dose.
Subject:
[+]
Antitubercular Agents
Diarylquinolines
Humans
Linezolid
Tuberculosis
Tuberculosis, Multidrug-Resistant

Source:
Emerg Infect Dis. 27(1):332-334
Pubmed ID:
33227229
Pubmed Central ID:
PMC7774582
Document Type:
Journal Article
Place as Subject:
South Africa ; United States
South Africa ; United States Less -
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:626836f2d662b3c90eb24bff03b21db20069426e84c1f5db36da5b16735559c9
File Type:

Supporting Files

• 20-3766.nxml

  xml

More +